Status:
COMPLETED
Motivating a Spectrum of Cancer Patients to Quit Smoking
Lead Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Cancer
Smoking
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study will assess feasibility and acceptability of an intervention designed to increase smoking cessation motivation among patients with a cancer not widely known to be smoking related.
Eligibility Criteria
Inclusion
- Smoking at least 1 cigarette in previous 30 days
- Diagnosis of breast, colorectal, gynecological, skin melanoma, or bladder cancer within the last 6 months
- Able to read/write English
- Able to give informed consent
- Not currently enrolled in a smoking cessation program
Exclusion
- Having distant metastases
- Male patients with breast cancer
Key Trial Info
Start Date :
June 14 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 2 2022
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT04914000
Start Date
June 14 2021
End Date
June 2 2022
Last Update
April 25 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Moffitt Cancer Center
Tampa, Florida, United States, 33612